Development of a Large-Scale Synthetic Route to Manufacture (−)-Huperzine A
摘要:
A safe, practical and scalable process for manufacture of (-)-huperzine A has been developed and scaled up to manufacture several hundred grams of (-)-huperzine A with chemical and optical purity of >99%. The process consists of 11 chemical stages starting from commercially available materials with only nine isolation steps and no chromatography purification. This process provides a reliable and cost-effective source of synthetic (-)-huperzine A and its derivatives for pharmaceutical and nutraceutical markets.
Development of a Large-Scale Synthetic Route to Manufacture (−)-Huperzine A
摘要:
A safe, practical and scalable process for manufacture of (-)-huperzine A has been developed and scaled up to manufacture several hundred grams of (-)-huperzine A with chemical and optical purity of >99%. The process consists of 11 chemical stages starting from commercially available materials with only nine isolation steps and no chromatography purification. This process provides a reliable and cost-effective source of synthetic (-)-huperzine A and its derivatives for pharmaceutical and nutraceutical markets.
Development of a Large-Scale Synthetic Route to Manufacture (−)-Huperzine A
作者:Stephen R. Tudhope、Julie A. Bellamy、Anthony Ball、Dewakar Rajasekar、Manouchehr Azadi-Ardakani、Harihara Subramanian Meera、Jesudoss Mercy Gnanadeepam、Ramanathan Saiganesh、Frank Gibson、Linli He、Carl H. Behrens、Gail Underiner、Judith Marfurt、Nathalie Favre
DOI:10.1021/op200360b
日期:2012.4.20
A safe, practical and scalable process for manufacture of (-)-huperzine A has been developed and scaled up to manufacture several hundred grams of (-)-huperzine A with chemical and optical purity of >99%. The process consists of 11 chemical stages starting from commercially available materials with only nine isolation steps and no chromatography purification. This process provides a reliable and cost-effective source of synthetic (-)-huperzine A and its derivatives for pharmaceutical and nutraceutical markets.